Showing results (1-10 of 379) with videos related to
Sort By:
Pageof 38
Dermatologie (Heidelberg, Germany)|May 27, 2024
[Side effects of dermato-oncologic therapies]Jessica C Hassel, Lisa ZimmerJournal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 5, 2016
Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanomaKatharina C Kähler, Jessica C Hassel, Lucie Heinzerling, et al.British Journal of Cancer|October 26, 2021
Checkpoint blocker induced autoimmunity as an indicator for tumour efficacy in melanomaJessica C HasselJournal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 4, 2020
Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma - an updateKatharina C Kähler, Jessica C Hassel, Lucie Heinzerling, et al.Cancer Medicine|December 22, 2017
Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanomaJessica C Hassel, Kristina Buder-Bakhaya, Carolin Bender, et al.European Journal of Cancer (Oxford, England : 1990)|September 4, 2020
Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world data of a retrospective, multicenter studyMartin Salzmann, Ulrike Leiter, Carmen Loquai, et al.Frontiers in Oncology|February 10, 2023
Targeting the cMET pathway to enhance immunotherapeutic approaches for mUM patientsDevayani Machiraju, Jessica C HasselPathologie (Heidelberg, Germany)|June 18, 2026
[Therapy of melanoma : Current standards and future perspectives]Isabel Hariri, Jessica C HasselCurrent Treatment Options in Oncology|April 5, 2022
Targeted Therapy for Melanomas Without BRAF V600 MutationsChristian Menzer, Jessica C HasselCancers|March 11, 2023
Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective StudyMartin Salzmann, Alexander Wald, Henner Stege, et al.Pageof 38